OUR MISSION: The D’Gama Lab conducts translational research at the intersection of developmental neuroscience, genetics/genomics, and neonatology. Our goal is to advance equitable precision medicine for infants and children with neurological and genetic conditions, especially infants with epilepsy and related neurogenetic disorders. We aim to accomplish this goal by conducting research across the translational spectrum: discovering fundamental underlying molecular genetic mechanisms (precision diagnoses) and evaluating their impact, enabling development of innovative precision therapies and readiness for clinical trials, and implementing precision medicine equitably for these populations. Ultimately, we hope to improve outcomes for pediatric patients with these conditions and their families.